[go: up one dir, main page]

BR9915236A - Derivados da eritromicina, seu respectivo processo de preparação e sua respectiva aplicação enquanto medicamentos - Google Patents

Derivados da eritromicina, seu respectivo processo de preparação e sua respectiva aplicação enquanto medicamentos

Info

Publication number
BR9915236A
BR9915236A BR9915236-3A BR9915236A BR9915236A BR 9915236 A BR9915236 A BR 9915236A BR 9915236 A BR9915236 A BR 9915236A BR 9915236 A BR9915236 A BR 9915236A
Authority
BR
Brazil
Prior art keywords
medicines
preparation process
erythromycin derivatives
respective application
application
Prior art date
Application number
BR9915236-3A
Other languages
English (en)
Inventor
Constantin Agouridas
Alexis Denis
Claude Fromentin
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BR9915236A publication Critical patent/BR9915236A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Patente de Invenção: "DERIVADOS DA ERITROMICINA, SEU RESPECTIVO PROCESSO DE PREPARAçãO E SUA RESPECTIVA APLICAçãO ENQUANTO MEDICAMENTOS". A invenção tem por objeto, a título de produtos novos, os compostos de fórmula (I) na qual X representa um átomo de hidrogênio ou um átomo de halogênio e Z representa um átomo de hidrogênio de um ácido, assim como seus sais de adição com os ácidos. Os compostos de fórmula (I) apresentam propriedades antibióticas.
BR9915236-3A 1998-11-10 1999-11-09 Derivados da eritromicina, seu respectivo processo de preparação e sua respectiva aplicação enquanto medicamentos BR9915236A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9814145A FR2785612A1 (fr) 1998-11-10 1998-11-10 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1999/002718 WO2000027857A2 (fr) 1998-11-10 1999-11-09 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
BR9915236A true BR9915236A (pt) 2002-01-08

Family

ID=9532584

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915236-3A BR9915236A (pt) 1998-11-10 1999-11-09 Derivados da eritromicina, seu respectivo processo de preparação e sua respectiva aplicação enquanto medicamentos

Country Status (28)

Country Link
US (2) US6455505B2 (pt)
EP (1) EP1016669B1 (pt)
JP (1) JP4698783B2 (pt)
KR (1) KR100567695B1 (pt)
CN (2) CN1240708C (pt)
AR (1) AR025814A1 (pt)
AT (1) ATE232879T1 (pt)
AU (1) AU766138B2 (pt)
BR (1) BR9915236A (pt)
CA (1) CA2350651C (pt)
CZ (1) CZ20011622A3 (pt)
DE (1) DE69905447T2 (pt)
DK (1) DK1016669T3 (pt)
EA (1) EA200100533A1 (pt)
ES (1) ES2189365T3 (pt)
FR (1) FR2785612A1 (pt)
HR (1) HRP20010335B1 (pt)
HU (1) HUP0104035A3 (pt)
IL (2) IL142996A0 (pt)
NO (1) NO20012272L (pt)
NZ (1) NZ511609A (pt)
PL (1) PL348098A1 (pt)
PT (1) PT1016669E (pt)
SI (1) SI20640A (pt)
TR (1) TR200101286T2 (pt)
TW (1) TWI237027B (pt)
WO (1) WO2000027857A2 (pt)
ZA (1) ZA200103801B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20012675A3 (cs) * 1999-01-27 2002-04-17 Pfizer Products Inc. Ketolidová antibiotika
CA2373117C (en) 1999-05-24 2006-02-28 Pfizer Products Inc. 13-methyl-erythromycin derivatives
EP1167376B1 (en) 2000-06-30 2004-07-14 Pfizer Products Inc. Macrolide antibiotics
JP2004017020A (ja) * 2002-06-20 2004-01-22 Sony Corp コーティング方法および被コーティング粒子
EP3738591A3 (en) 2003-03-10 2021-03-24 Merck Sharp & Dohme Corp. Novel antibacterial agents
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2009055557A1 (en) * 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
HRP20160222T1 (hr) * 2008-10-24 2016-04-08 Cempra Pharmaceuticals, Inc. Biozaštite uporabom makrolida koji sadrže triazol
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
AU2010292010B2 (en) 2009-09-10 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
NZ602544A (en) 2010-03-22 2014-11-28 Cempra Pharmaceuticals Inc Crystalline forms of a macrolide, and uses therefor
RU2608390C2 (ru) 2010-05-20 2017-01-18 Семпра Фармасьютикалз, Инк. Способы получения макролидов и кетолидов, и промежуточных соединений для их получения
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
HK1205939A1 (en) 2012-03-27 2015-12-31 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
HK1217665A1 (zh) 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CA3130061C (en) * 2013-04-04 2024-05-28 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
US10633407B2 (en) 2014-10-08 2020-04-28 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
JP2018509452A (ja) 2015-03-25 2018-04-05 プレジデント アンド フェローズ オブ ハーバード カレッジ 修飾デソサミン糖をもつマクロライドおよびその使用
EP3190122A1 (en) * 2016-01-08 2017-07-12 LEK Pharmaceuticals d.d. A novel synthetic pathway towards solithromycin and purification thereof
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
FR2669337B1 (fr) * 1990-11-21 1995-03-24 Roussel Uclaf Nouveaux derives descladinosyles de l'erythromycine, leur procede de preparation et leur application comme medicaments.
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CA2263972C (en) * 1996-09-04 2008-01-29 Abbott Laboratories 6-o-substituted ketolides having antibacterial activity
WO1998040392A1 (fr) * 1997-03-10 1998-09-17 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a

Also Published As

Publication number Publication date
ES2189365T3 (es) 2003-07-01
EA200100533A1 (ru) 2001-10-22
AR025814A1 (es) 2002-12-18
DE69905447D1 (de) 2003-03-27
NO20012272L (no) 2001-07-10
HUP0104035A3 (en) 2003-12-29
JP2000143689A (ja) 2000-05-26
NZ511609A (en) 2003-07-25
PL348098A1 (en) 2002-05-06
IL142996A0 (en) 2002-04-21
PT1016669E (pt) 2003-07-31
TR200101286T2 (tr) 2001-09-21
HRP20010335A2 (en) 2002-06-30
US6407257B1 (en) 2002-06-18
US20020013281A1 (en) 2002-01-31
CA2350651C (fr) 2010-07-20
AU766138B2 (en) 2003-10-09
HUP0104035A2 (hu) 2002-02-28
WO2000027857A2 (fr) 2000-05-18
FR2785612A1 (fr) 2000-05-12
KR20010080970A (ko) 2001-08-25
TWI237027B (en) 2005-08-01
AU1052600A (en) 2000-05-29
ATE232879T1 (de) 2003-03-15
US20020028781A1 (en) 2002-03-07
DE69905447T2 (de) 2003-07-24
US6455505B2 (en) 2002-09-24
NO20012272D0 (no) 2001-05-09
ZA200103801B (en) 2002-05-10
CN1333782A (zh) 2002-01-30
DK1016669T3 (da) 2003-05-26
EP1016669A1 (fr) 2000-07-05
CN1240708C (zh) 2006-02-08
IL142996A (en) 2006-12-10
KR100567695B1 (ko) 2006-04-05
CZ20011622A3 (cs) 2001-09-12
CN1814592A (zh) 2006-08-09
JP4698783B2 (ja) 2011-06-08
CA2350651A1 (fr) 2000-05-18
WO2000027857A3 (fr) 2000-08-17
HRP20010335B1 (en) 2003-08-31
EP1016669B1 (fr) 2003-02-19
CN100351238C (zh) 2007-11-28
SI20640A (sl) 2002-02-28

Similar Documents

Publication Publication Date Title
BR9915236A (pt) Derivados da eritromicina, seu respectivo processo de preparação e sua respectiva aplicação enquanto medicamentos
BR0112986A (pt) Compostos azabicìclicos, o respectivo preparo e a respectiva utilização como medicamentos, notadamente como antibacteriano
BR9915967A (pt) Derivados de propanolamina substituìdos por arila, proceso para sua preparação, medicamentos contendo estes compostos e seu uso
BR0009641A (pt) Derivados de 1,4-benzotiazepin-1,1-dióxido, substituìdos com radicais de açúcar, processo para produção dos mesmos, medicamentos contendo esses compostos e sua utilização
PT1295890E (pt) Novos derivados de pirazina ou os seus sais, composicoes farmaceuticas que os contem, e compostos intermedios utilizados na sua producao
BR0116482A (pt) Derivados de difenilazetidinona, processo para a preparação, medicamentos contendo esses compostos e seu emprego.
BR0213242A (pt) Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto
BR0313732A (pt) Compostos de pirimido tendo atividade antiproliferativa
BR0012880A (pt) Derivados de mutilina e seu uso como antibacterianos
BR0116431A (pt) Antibióticos de macrolìdeos
BR9906735A (pt) Composição farmacêutica lìquida aquosa
FI942074A0 (fi) nor-sappijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
TR200003632T2 (tr) Benzotiyepin-1,1-dioksid türevleri, üretim yöntemi, bunları içeren ilaçlar.
BR9905735A (pt) Derivados da eritromicina, seu processo de preparação e sua aplicação como medicamentos
BR9910179A (pt) Composto, composição farmacêutica, uso de um composto, e, processo para tratar uma doença ou condição mediada por fator xa em um animal de sangue quente
BR9914929A (pt) Fenil - alquenoil - guanidinas substituìdas de ácido biliar, processos para a sua preparação, sua aplicação como medicamentos ou agentes diagnósticos, assim como medicamento contendo as mesmas
BR9802804A (pt) Compostos benzimidazol, benzoxazol e benzotiazol, processo para sua preparação e composições farmacéuticas contendo os mesmos.
BR9910032A (pt) Tienopirimidinas
FR2412565A1 (fr) Nouveaux derives de type n-acyl-2', n-alkyl-2', di-n-acyl-4,2', di-n-alkyl-4,2', n-acyl-4 n-alkyl-2' et n-alkyl-4 n-acyl-2', desoxy-2 fortimicine b
DK0866791T3 (da) Diaminopyrimidiner, farmaceutiske præparater indeholdende disse og deres anvendelse som antibakterielle midler
BR0011141A (pt) Composição de éter de celulose para cápsulas isentas de tubidez e processo para sua preparação
BR9915027A (pt) Derivados de 1,3-diaril-2-piridin-2-il-3-(3-piridin-2-ilamino)-propanol susbtituìdos, processos para a sua preparação, medicamentos contendo estes compostos e seu emprego
BR0106248A (pt) Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos
BR0008511A (pt) Sistemas tiazol policìclicos e seu emprego como anoréticos contendo estes compostos
BR9810622A (pt) 3-benzilpiperidinas

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]

Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time